Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




JIB 2010 Meeting Focuses Medical Biology Reform

By LabMedica International staff writers
Posted on 01 Dec 2010
At the Journées Internationales de Biologie (JIB) 2010 discussions were focused on the reform of medical biology, and many speakers expressed their opinions with regard to the major challenges that are revolutionizing the profession. More...
Restructuring and adaptation of the biology sector to meet the economic needs stemming from the French reform, were the main topics discussed in relation to this theme.

The "accreditation special” session explained both the theoretical and practical aspects of this very complex and obligatory process, and it provided the audience with the essential keys to simplifying ways in which accreditation could be achieved.

Jean Benoit, president of the JIB commented, "Taking the future of the profession in hand, playing our full medical role in the interpretation of results, involvement [in prescribing] but also in ongoing care, providing opportunities for young people by offering them suitable conditions in our laboratories; these are some of the many challenges and imperatives that the profession must respond to within the very short term.”

The organizational challenges of the proposed reform include the willingness of the biomedical profession to respond positively to the quality requirements for healthcare professionals as well as the necessity for an interprofession and interdisciplinary approach inherent in better medical care for patients.

Speakers from a large number of countries in the Young Scientists Task work group of the International Federation of Laboratory Medicine emphasized the need for encouraging collaboration and exchanges via networks of biologists. Their ultimate aim is to avoid the emergence of "two speed biology”--a high performance, high quality biology established in industrialized countries, which would be difficult for biologists from emerging countries to access.

The second main theme the meeting dealt with was Health and Environment. The discussions confirmed the dominant role of biology in diagnostics and the identification of environmental factors involved in numerous pathologies. Sessions were designed to encourage biologists to become involved in prevention programs and health initiatives launched by public authorities.

The Café Scientifique, a venue for opinions, was a great success, with 14 slots over the 3 days. In addition BioMI (Molecular biology initiatives), the showcase for innovation in biology, captured the interest of scientists in the advanced technologies.

The meeting took place La Défense CNIT Congress Center from November 3-5, 2010. There was an increase in the number of participants over previous years, with more foreign visitors, especially from European countries. The total number of visitors was 9,271 and there were 178 exhibitors including 21 foreign companies.

Related Links:

Journées Internationales de Biologie



Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.